糖心原创

Contact

• workRoom B208 Nottingham Biodiscovery Institute
  University Park
  Nottingham
  NG7 2RD
  UK
• work07880828138
• Cathy.Merry@nottingham.ac.uk

Biography

Sept. 2015-Aug 2019 Associate Professor in Stem Cell Biology Division of Cancer and Stem Cells, School of Medicine, 糖心原创

Aug. 2014-Aug. 2015 Leverhulme Trust International Research Fellow Dept. of Medical Biochemistry, Uppsala University, Sweden

June 2013-Sept. 2015 Reader in Stem Cell Glycobiology, University of Manchester Honorary NHS Researcher, Materials Science Centre, School of Materials.

August 2011- June 2013 Senior Lecturer in Biomedical Materials, University of Manchester, Honorary NHS Researcher, Materials Science Centre, School of Materials.

March 2006-July 2011 Lecturer in Biomedical Materials, University of Manchester Honorary NHS Researcher, Materials Science Centre, School of Materials.

March 2004-March 2006 Research Fellow, University of Manchester Cancer Research UK Department of Medical Oncology, Christie Hospital Research Centre

Jan 1999-March 2004 Post Doctoral Research Associate, University of Manchester Cancer Research UK Department of Medical Oncology, Christie Hospital Research Centre. Supervisor: Professor John Gallagher

Sept 1995-Jan 1999 PhD student University of Manchester Cancer Research UK Department of Medical Oncology, Christie Hospital Research Centre

I lead a lively, dynamic, interdisciplinary research group that is discovering previously unknown mechanistic regulation of cell behaviour by glycans in health and disease and, more broadly, the role of the pericellular matrix in controlling cell behaviour.

To do this, we create stem cell-based tools and novel 3D culture environments that now support large collaborative research projects in cancer and inherited rare disease modelling.

I currently sit on the board of and I'm delighted to support various of their activities including hosting a series of international online sessions discussing alternatives to animal-derived matrices and recently, a focused event to discuss the move towards non-animal derived antibodies for commercial and academic users.

Publications over the past 5 years have included the first report of defects in an enzyme of the heparan sulphate pathway in humans (HS2ST) as well as multiple in vitro models for glioblastoma and medulloblastoma. In partnership with local colleagues, we continue to develop of a novel glycan analysis method which is transforming the detection of glycosaminoglycans in situ and in patient sourced materials.

Continuing the strong international theme of my research, I have been awarded an Honorary Doctorate by Uppsala University and now hold a 20% position with them. I have initiated new collaborations with Australia, Malaysia, Denmark and the USA, encouraging others in Nottingham to share these valuable relationships. I continue to be invited to present our work at international conferences and have been elected by my peers to chair our most significant meeting () in 2026, as well as co-chairing the 2024 Biochemical Society Harden Conference. I have been lead author for the Proteoglycans and Sulfated Glycosaminoglycans chapter of the primary textbook in my area as well as contributing to collections that highlight the rapid progress within the glycosaminoglycan field

Expertise Summary

We have specific expertise in methods for the structural and functional analysis of glycosaminoglycans, in particular heparan sulphate. We have a variety of cell-based tools (KOs/OE lines) and data associated with these which we are keen to share with collaborators.

We also have expertise in 3D in vitro modelling, in particular self-assembling peptide hydrogels. Part of this work is now being commercialised () but we are still keen to collaborate on academic applications of these materials.

Teaching Summary

I apply experience and knowledge of innovative teaching methods and examination strategies to invigorate teaching practice. I teach on the popular Translational Technologies for Stem Cells module.… read more

Research Summary

Current research within the Stem Cell Glycobiology Group has two major themes. One is the investigation of the structure/function relationships of the pericellular matrix in controlling cell… read more

Recent Publications

• LINKE, FRANZISKA, JOHNSON, JAMES E. C., KERN, STEFANIE, BENNETT, CHRISTOPHER D., LOURDUSAMY, ANBARASU, LEA, DANIEL, CLIFFORD, STEVEN C., MERRY, CATHERINE L. R., STOLNIK, SNOW, ALEXANDER, MORGAN R., PEET, ANDREW C., SCURR, DAVID J., GRIFFITHS, RIAN L., GRABOWSKA, ANNA M., KERR, IAN D. and COYLE, BETH, 2023. Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging ACTA NEUROPATHOLOGICA COMMUNICATIONS. 11(1),
• MENDONCA, TANIA, LIS-SLIMAK, KATARZYNA, MATHESON, ANDREW B., SMITH, MATTHEW G., ANANE-ADJEI, AKOSUA B., ASHWORTH, JENNIFER C., CAVANAGH, ROBERT, PATERSON, LYNN, DALGARNO, PAUL A., ALEXANDER, CAMERON, TASSIERI, MANLIO, MERRY, CATHERINE L. R. and WRIGHT, AMANDA J., 2023. OptoRheo: Simultaneous in situ micro-mechanical sensing and imaging of live 3D biological systems COMMUNICATIONS BIOLOGY. 6(1),
• JAMES, JENNA R., CURD, JOHNATHAN, ASHWORTH, JENNIFER C., ABUHANTASH, MAYS, GRUNDY, MARTIN, SEEDHOUSE, CLAIRE H., ARKILL, KENTON P., WRIGHT, AMANDA J., MERRY, CATHERINE L. R. and THOMPSON, ALEXANDER, 2023. Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 24(4),
• HANSON, PETRA, ARKILL, KENTON P., MERRY, CATHERINE L. R., HUSSAIN, MOHAMMED S., MEERSMANN, THOMAS, RANDEVA, HARPAL S., PAVLOVSKAYA, GALINA E., O'HARE, PAUL and BARBER, THOMAS M., 2022. Novel perspectives of sodium handling in type 2 diabetes mellitus EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM. 17(4), 333-341

• View all publications

Related to my own research, I have developed a commercialisation strategy that currently focuses on two key areas; the development of hydrogels for in vitro 3D culture, and an analytical method able to discriminate between glycosaminoglycans at previously undetectable levels.

The hydrogel work has been pursued using the BBSRC ICASe programme. On the back of positive progress, we were recently successful in the linked Innovate UK funding round and will be spinning-out our company, in 2023. This will provide new opportunities for commercial collaboration as well as a great opportunity for a previous PhD student from my group (Dr. John Curd) who has developed an strong entrepreneurial skill set.

The ToF-SIMS analytical work has now been further developed to link with the ORBI-SIMS platform at UoN, with great success. Dr Andrew Hook and I have a patent filed and have used EPSRC IAA funding to develop a network of potential customers. We will look to commercialise this soon. This area is also in high demand for academic / clinical collaborations and is supporting multiple grant applications.

A major part of the NHIP initiative is around supporting KE and developing potential spinouts and licencing opportunities. I have developed new links with the KE office at UoN as well as the Hayden Green Institute, the Business School and others in order to make this as effective as possible. UoN nurtures researchers from a diverse array of backgrounds, innovating and providing solutions to challenges from within their faculties and schools. NHIP provides a mechanism to harness that creativity and focus it on providing solutions to unmet clinical need across a diverse range of clinical settings

I apply experience and knowledge of innovative teaching methods and examination strategies to invigorate teaching practice. I teach on the popular Translational Technologies for Stem Cells module. Starting in 2022 I established and convene the ONCG4026 module which is for 4^th year MSci Cancer Sciences students during their placement year. This includes support, guidance and the submission of a placement proposal.

I additionally teach on: BIOS4122 (Animal Biotechnology), ONC3002 (Tumour Microenvironment) - including co-running workshops and practical sessions and ONC4012 (Cell, Developmental and Molecular Biology)

I use my experience of flipped teaching, to support the contributing lecturers to provide an inclusive teaching experience that's high-quality, tailored to student needs, reflects the interdisciplinary and translational space covered by the modules I convene and the specialist lectures I teach, and provide a positive experience for the student journey.

I have supported over 28 PhD students, focusing on high quality 'big' research with impact on human health and disease. I often co-supervise, providing support in my specialist areas of 3D models of disease, matrix biology and glycosaminoglycans. Again, my experience in support of students working in the translational/interdisciplinary space is valuable in ensuring a positive student experience

I support staff professional development to improve our grant success rate and to help staff fulfil their career goals. I have linked up with research and development leads from across the University to run training relevant for interdisciplinary researchers, using BDI as a hub to support initiatives across the University

Current Research

Current research within the Stem Cell Glycobiology Group has two major themes. One is the investigation of the structure/function relationships of the pericellular matrix in controlling cell behaviour and the other is in the use of in vitro 3D cell culture models. Often, these combine. We support many co-supervised studentships with collaborators within as well as outside of the UoN, working on modelling fibrosis, cancer and early development as well as developing new tools for the analysis and structural characterisation of glycosaminoglycans.

Understanding the role of glycosylated matrices in early development

Developmental events such as somitogenesis, a segmentation process that gives rise to vertebrae and skeletal muscles, rely on interactions with the extracellular matrix (ECM). These processes are generally studied in vivo using genetically modified mouse embryos isolated from pregnant mice that have been killed specifically for this purpose. When studying developmental processes in vitro, Matrigel is often used to provide matrix components, including proteins and sugars. Matrigel is derived from mouse tumours. Its components are not precisely defined and there is significant batch-to-batch variation. These limitations hamper the widespread use of in vitro models, such as gastruloids, 3D aggregates of embryonic stem cells, from being taken up to replace the use of mice for studying developmental events that require ECM. , we have previously developed synthetic hydrogels that support 3D culture for multiple cell types. These hydrogels are adaptable and various proteins and sugars can be added to replicate the components found in the ECM. A PhD student, Stephanie Barnard-Khan will now work with the SCG group and , a former NC3Rs-funded David Sainsbury Fellow, to combine the hydrogle technology with the use of gastruloids as part of her NC3Rs-funded PhD (https://www.nc3rs.org.uk/our-portfolio/exploring-role-matrix-encapsulation-early-developmental-decisions-using-non-animal).

Novel approaches to the creation of cultured meats

This work is a collaboration with Prof. Neil Thomas in the School of Chemistry and Prof. Ramiro Alberio from Biosciences. Using Prof. Ramiro's recent breakthroughs in the isolation of stem cells from cattle and combining these with hydrogels functionalised using methods developed by Prof. Thomas. A BBSRC DTP student, Charlotte Knight is currently working on this project.

• LINKE, FRANZISKA, JOHNSON, JAMES E. C., KERN, STEFANIE, BENNETT, CHRISTOPHER D., LOURDUSAMY, ANBARASU, LEA, DANIEL, CLIFFORD, STEVEN C., MERRY, CATHERINE L. R., STOLNIK, SNOW, ALEXANDER, MORGAN R., PEET, ANDREW C., SCURR, DAVID J., GRIFFITHS, RIAN L., GRABOWSKA, ANNA M., KERR, IAN D. and COYLE, BETH, 2023. Identifying new biomarkers of aggressive Group 3 and SHH medulloblastoma using 3D hydrogel models, single cell RNA sequencing and 3D OrbiSIMS imaging ACTA NEUROPATHOLOGICA COMMUNICATIONS. 11(1),
• MENDONCA, TANIA, LIS-SLIMAK, KATARZYNA, MATHESON, ANDREW B., SMITH, MATTHEW G., ANANE-ADJEI, AKOSUA B., ASHWORTH, JENNIFER C., CAVANAGH, ROBERT, PATERSON, LYNN, DALGARNO, PAUL A., ALEXANDER, CAMERON, TASSIERI, MANLIO, MERRY, CATHERINE L. R. and WRIGHT, AMANDA J., 2023. OptoRheo: Simultaneous in situ micro-mechanical sensing and imaging of live 3D biological systems COMMUNICATIONS BIOLOGY. 6(1),
• JAMES, JENNA R., CURD, JOHNATHAN, ASHWORTH, JENNIFER C., ABUHANTASH, MAYS, GRUNDY, MARTIN, SEEDHOUSE, CLAIRE H., ARKILL, KENTON P., WRIGHT, AMANDA J., MERRY, CATHERINE L. R. and THOMPSON, ALEXANDER, 2023. Hydrogel-Based Pre-Clinical Evaluation of Repurposed FDA-Approved Drugs for AML INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 24(4),
• HANSON, PETRA, ARKILL, KENTON P., MERRY, CATHERINE L. R., HUSSAIN, MOHAMMED S., MEERSMANN, THOMAS, RANDEVA, HARPAL S., PAVLOVSKAYA, GALINA E., O'HARE, PAUL and BARBER, THOMAS M., 2022. Novel perspectives of sodium handling in type 2 diabetes mellitus EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM. 17(4), 333-341
• LINKE, FRANZISKA, ALDIGHIERI, MACHA, LOURDUSAMY, ANBARASU, GRABOWSKA, ANNA M., STOLNIK, SNOW, KERR, IAN D., MERRY, CATHERINE L. R. and COYLE, BETH, 2021. JOURNAL OF PATHOLOGY. 253(3), 326-338
• THOMPSON, J. L., PIJUAN-GALITO, S., ASHWORTH, J. C., NIZAMUDEEN, Z., BOVEE, J., SMITH, J., HOOK, A., ARKILL, K. P., ALEXANDER, M. R., KJELLEN, L. and MERRY, C. L. R., 2021. Investigating glycosaminoglycans in development using human stem cells and fully defined 3D cell culture environments INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. 102(2), 130-131
• HOOK, ANDREW L., HOGWOOD, JOHN, GRAY, ELAINE, MULLOY, BARBARA and MERRY, CATHERINE L. R., 2021. Communications Chemistry. 4(1),
• VINEL, CLAIRE, ROSSER, GABRIEL, GUGLIELMI, LOREDANA, CONSTANTINOU, MYRIANNI, POMELLA, NICOLA, ZHANG, XINYU, BOOT, JAMES R., JONES, TANIA A., MILLNER, THOMAS O., DUMAS, ANAELLE A., RAKYAN, VARDHMAN, REES, JEREMY, THOMPSON, JAMIE L., VUONONVIRTA, JUHO, NADKARNI, SUCHITA, EL ASSAN, TEDANI, ALEY, NATASHA, LIN, YUNG-YAO, LIU, PENTAO, NELANDER, SVEN, SHEER, DENISE, MERRY, CATHERINE L. R., MARELLI-BERG, FEDERICA, BRANDNER, SEBASTIAN and MARINO, SILVIA, 2021. Comparative epigenetic analysis of tumour initiating cells and syngeneic EPSC-derived neural stem cells in glioblastoma NATURE COMMUNICATIONS. 12(1),
• MACIEJ-HULME, MARISSA L., DUBAISSI, EAMON, SHAO, CHUN, ZAIA, JOSEPH, AMAYA, ENRIQUE, FLITSCH, SABINE L. and MERRY, CATHERINE L. R., 2021. Selective Inhibition of Heparan Sulphate and Not Chondroitin Sulphate Biosynthesis by a Small, Soluble Competitive Inhibitor INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES. 22(13),
• JOHNSON, B. B., HOLMES, T. L., THOMPSON, J. L., LORD, M., DENNING, C., WHITELOCK, J., MERRY, C. L. R. and SMITH, JAMES, 2021. A CRISPR/Cas9 in vitro human-induced pluripotent stem cell (hiPSC) model to investigate the role of perlecan in cardiovascular fibrotic disease INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. 102(2), 126-127
• PIJUAN-GALITO, S., THOMPSON, J. L., LEWIS, L. C., TAMM, C., ANNEREN, C., DENNING, C. and MERRY, C. L. R., 2021. Inter-alpha-inhibitor supports in vitro expansion of both primed and naive human pluripotent stem cells in defined, xeno-free conditions INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. 102(2), 133-134
• MERRY, CATHERINE L. R., 2021. Exciting New Developments and Emerging Themes in Glycosaminoglycan Research JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY. 69(1), 9-11
• ASHWORTH JC, THOMPSON JL, JAMES JR, SLATER CE, PIJUAN-GALITO S, LIS-SLIMAK K, HOLLEY RJ, MEADE KA, THOMPSON A, ARKILL KP, TASSIERI M, WRIGHT AJ, FARNIE G and MERRY, C. L. R., 2020. Matrix Biology. 85-86, 15-33
• ASHWORTH JC, MORGAN RL, LIS-SLIMAK K, MEADE KA, JONES S, SPENCE K, SLATER CE, THOMPSON JL, GRABOWSKA AM, CLARKE RB, FARNIE, G and MERRY CLR, 2020. JOVE - Journal of Visualized Experiments.
• JOHNSON, JAMES, LINKE, FRANZISKA, MERRY, CATHERINE L. R. and COYLE, BETH, 2020. ELUCIDATING HOW NOVEL EXTRACELLULAR MATRIX SUBTYPES DIFFERENTIALLY IMPACT THE SURVIVAL OF MEDULLOBLASTOMA SUBGROUPS NEURO-ONCOLOGY. 22, 405-405
• SCHNEEBERGER, PAULINE E., VON ELSNER, LEONIE, BARKER, EMMA L., MEINECKE, PETER, MARQUARDT, IRIS, ALAWI, MALIK, STEINDL, KATHARINA, JOSET, PASCAL, RAUCH, ANITA, ZWIJNENBURG, PETRA J. G., WEISS, MARJAN M., MERRY, CATHERINE L. R. and KUTSCHE, KERSTIN, 2020. Bi-allelic Pathogenic Variants in HS2ST1 Cause a Syndrome Characterized by Developmental Delay and Corpus Callosum, Skeletal, and Renal Abnormalities AMERICAN JOURNAL OF HUMAN GENETICS. 107(6), 1044-1061
• THOMPSON, J. L., PIJUAN-GALITO, S., ASHWORTH, J. C., DOWDING, K. S., NASIR, A., SMITH, J. G. W., WILPSHAAR, T., BOVEE, J., LIU, J., DENNING, C., ALEXANDER, M. R. and MERRY, C. L. R., 2018. Matrix-inspired biomaterials for cell phenotype control INTERNATIONAL JOURNAL OF EXPERIMENTAL PATHOLOGY. 99(6), A3-A3
• LINKE, FRANZISKA, MERRY, CATHERINE L. R., GRABOWSKA, ANNA M., STOLNIK-TRENKIC, SNOW, KERR, IAN D. and COYLE, BETH, 2018. MODELLING MEDULLOBLASTOMA INVASION AND CHEMORESISTANCE IN A 3D HYALURONAN HYDROGEL SYSTEM NEURO-ONCOLOGY. 20, 137-137
• BORLAND, SAMANTHA J., MORRIS, THOMAS G., BORLAND, SHONA C., MORGAN, MARK R., FRANCIS, SHEILA E., MERRY, CATHERINE L. R. and CANFIELD, ANN E., 2017. Regulation of vascular smooth muscle cell calcification by syndecan-4/FGF-2/PKC alpha signalling and cross-talk with TGF beta CARDIOVASCULAR RESEARCH. 113(13), 1639-1652
• AYERST, BETHANIE I., MERRY, CATHERINE L. R. and DAY, ANTHONY J., 2017. The Good the Bad and the Ugly of Glycosaminoglycans in Tissue Engineering Applications PHARMACEUTICALS. 10(2),
• AYERST, BETHANIE I., SMITH, RAYMOND A. A., NURCOMBE, VICTOR, DAY, ANTHONY J., MERRY, CATHERINE L. R. and COOL, SIMON M., 2017. Growth Differentiation Factor 5-Mediated Enhancement of Chondrocyte Phenotype Is Inhibited by Heparin: Implications for the Use of Heparin in the Clinic and in Tissue Engineering Applications TISSUE ENGINEERING PART A. 23(7-8), 275-292
• PIJUAN-GALIT脫 S, TAMM C, SCHUSTER J, SOBOL M, FORSBERG L, MERRY CL and ANNER脡N C, 2016. Nature communications. 7, 12170
• 2016. The Journal of biological chemistry. (In Press.)
• WAN, SIMON, BORLAND, SAMANTHA, RICHARDSON, STEPHEN M., MERRY, CATHERINE L. R., SAIANI, ALBERTO and GOUGH, JULIE E., 2016. Self-assembling peptide hydrogel for intervertebral disc tissue engineering ACTA BIOMATERIALIA. 46, 29-40
• DELIGNY, AUDREY, DIERKER, TABEA, DAGALV, ANDERS, LUNDEQUIST, ANDERS, ERIKSSON, INGER, NAIRN, ALISON V., MOREMEN, KELLEY W., MERRY, CATHERINE L. R. and KJELLEN, LENA, 2016. NDST2 (N-Deacetylase/N-Sulfotransferase-2) Enzyme Regulates Heparan Sulfate Chain Length JOURNAL OF BIOLOGICAL CHEMISTRY. 291(36), 18600-18607
• HOLLEY RJ, TAI G, WILLIAMSON AJ, TAYLOR S, CAIN SA, RICHARDSON SM, MERRY CL, WHETTON AD, KIELTY CM and CANFIELD AE, 2015. Stem cell reports. 4(3), 473-88
• WATSON HA, HOLLEY RJ, LANGFORD-SMITH KJ, WILKINSON FL, VAN KUPPEVELT TH, WYNN RF, WRAITH JE, MERRY CL and BIGGER BW, 2014. The Journal of biological chemistry. 289(52), 36194-203
• HOLLEY RJ, SMITH RA, VAN DE WESTERLO EM, PICKFORD CE, MERRY CL and VAN KUPPEVELT TH, 2014. Methods in molecular biology (Clifton, N.J.). 1229, 239-51
• HAWKINS K, KERAMARI M, SONCIN F, SEGAL JM, MOHAMET L, MIAZGA N, RITSON S, BOBOLA N, MERRY CL and WARD CM, 2014. Stem cells (Dayton, Ohio). 32(11), 2869-79
• HOLLEY RJ, MEADE KA and MERRY CL, 2014. Biochemical Society transactions. 42(3), 689-95
• BANKA S, CAIN SA, CARIM S, DALY SB, URQUHART JE, ERDEM G, HARRIS J, BOTTOMLEY M, DONNAI D, KERR B, KINGSTON H, SUPERTI-FURGA A, UNGER S, ENNIS H, WORTHINGTON J, HERRICK AL, MERRY CL, YUE WW, KIELTY CM and NEWMAN WG, 2014. Annals of the rheumatic diseases. 74(6), 1249-56
• AYERST BI, DAY AJ, NURCOMBE V, COOL SM and MERRY CL, 2014. Biochemical Society transactions. 42(3), 703-9
• GIANGRECO A and MERRY CL, 2014. Biochemical Society transactions. 42(3), 607-8
• KEENAN TD, PICKFORD CE, HOLLEY RJ, CLARK SJ, LIN W, DOWSEY AW, MERRY CL, DAY AJ and BISHOP PN, 2014. Investigative ophthalmology & visual science. 55(8), 5370-9
• SERGIJENKO A, LANGFORD-SMITH A, LIAO AY, PICKFORD CE, MCDERMOTT J, NOWINSKI G, LANGFORD-SMITH KJ, MERRY CL, JONES SA, WRAITH JE, WYNN RF, WILKINSON FL and BIGGER BW, 2013. Molecular therapy : the journal of the American Society of Gene Therapy. 21(10), 1938-49
• BALL SG, WORTHINGTON JJ, CANFIELD AE, MERRY CL and KIELTY CM, 2013. Stem cells (Dayton, Ohio). 32(3), 694-705
• BALDWIN AK, CAIN SA, LENNON R, GODWIN A, MERRY CL and KIELTY CM, 2013. Journal of cell science. 127(Pt 1), 158-71
• MEADE KA, WHITE KJ, PICKFORD CE, HOLLEY RJ, MARSON A, TILLOTSON D, VAN KUPPEVELT TH, WHITTLE JD, DAY AJ and MERRY CL, 2012. The Journal of biological chemistry. 288(8), 5530-8
• WILKINSON FL, HOLLEY RJ, LANGFORD-SMITH KJ, BADRINATH S, LIAO A, LANGFORD-SMITH A, COOPER JD, JONES SA, WRAITH JE, WYNN RF, MERRY CL and BIGGER BW, 2012. PloS one. 7(4), e35787
• LANGFORD-SMITH A, WILKINSON FL, LANGFORD-SMITH KJ, HOLLEY RJ, SERGIJENKO A, HOWE SJ, BENNETT WR, JONES SA, WRAITH J, MERRY CL, WYNN RF and BIGGER BW, 2012. Molecular therapy : the journal of the American Society of Gene Therapy. 20(8), 1610-21
• HAWKINS K, MOHAMET L, RITSON S, MERRY CL and WARD CM, 2012. Stem cells (Dayton, Ohio). 30(9), 1842-51
• CLARK SJ, KEENAN TD, FIELDER HL, COLLINSON LJ, HOLLEY RJ, MERRY CL, VAN KUPPEVELT TH, DAY AJ and BISHOP PN, 2011. Investigative ophthalmology & visual science. 52(9), 6511-21
• PICKFORD CE, HOLLEY RJ, RUSHTON G, STAVRIDIS MP, WARD CM and MERRY CL, 2011. Stem cells (Dayton, Ohio). 29(4), 629-40
• SONCIN F, MOHAMET L, RITSON S, HAWKINS K, BOBOLA N, ZEEF L, MERRY CL and WARD CM, 2011. PloS one. 6(7), e21463
• HOLLEY RJ, DELIGNY A, WEI W, WATSON HA, NI脩ONUEVO MR, DAG脛LV A, LEARY JA, BIGGER BW, KJELL脡N L and MERRY CL, 2011. The Journal of biological chemistry. 286(43), 37515-24
• SMITH RA, MEADE K, PICKFORD CE, HOLLEY RJ and MERRY CL, 2011. Biochemical Society transactions. 39(1), 383-7
• HOLLEY RJ, PICKFORD CE, RUSHTON G, LACAUD G, GALLAGHER JT, KOUSKOFF V and MERRY CL, 2010. The Journal of biological chemistry. 286(8), 6241-52
• SONCIN F, MOHAMET L, ECKARDT D, RITSON S, EASTHAM AM, BOBOLA N, RUSSELL A, DAVIES S, KEMLER R, MERRY CL and WARD CM, 2009. Stem cells (Dayton, Ohio). 27(9), 2069-80
• THORNTON K, SMITH AM, MERRY CL and ULIJN RV, 2009. Biochemical Society transactions. 37(Pt 4), 660-4
• MERRY CL and WARD CM, 2008. Development (Cambridge, England). 135(8), 1389-93
• BALDWIN RJ, TEN DAM GB, VAN KUPPEVELT TH, LACAUD G, GALLAGHER JT, KOUSKOFF V and MERRY CL, 2008. Stem cells (Dayton, Ohio). 26(12), 3108-18
• MERRY CL and ASTRAUTSOVA SA, 2008. EMBO reports. 9(7), 617-22
• SPENCER HL, EASTHAM AM, MERRY CL, SOUTHGATE TD, PEREZ-CAMPO F, SONCIN F, RITSON S, KEMLER R, STERN PL and WARD CM, 2007. Molecular biology of the cell. 18(8), 2838-51
• EASTHAM AM, SPENCER H, SONCIN F, RITSON S, MERRY CL, STERN PL and WARD CM, 2007. Cancer research. 67(23), 11254-62
• LAMANNA WC, KALUS I, PADVA M, BALDWIN RJ, MERRY CL and DIERKS T, 2007. Journal of biotechnology. 129(2), 290-307
• HELEN W, MERRY CL, BLAKER JJ and GOUGH JE, 2007. Biomaterials. 28(11), 2010-20
• JOHNSON CE, CRAWFORD BE, STAVRIDIS M, TEN DAM G, WAT AL, RUSHTON G, WARD CM, WILSON V, VAN KUPPEVELT TH, ESKO JD, SMITH A, GALLAGHER JT and MERRY CL, 2007. Stem cells (Dayton, Ohio). 25(8), 1913-23
• LAMANNA WC, BALDWIN RJ, PADVA M, KALUS I, TEN DAM G, VAN KUPPEVELT TH, GALLAGHER JT, VON FIGURA K, DIERKS T and MERRY CL, 2006. The Biochemical journal. 400(1), 63-73
• CLAMP A, BLACKHALL FH, HENRIOUD A, JAYSON GC, JAVAHERIAN K, ESKO J, GALLAGHER JT and MERRY CL, 2006. The Journal of biological chemistry. 281(21), 14813-22
• MERRY AH and MERRY CL, 2005. EMBO reports. 6(10), 900-3
• MURPHY KJ, MERRY CL, LYON M, THOMPSON JE, ROBERTS IS and GALLAGHER JT, 2004. The Journal of biological chemistry. 279(26), 27239-45
• TEN DAM GB, VAN DE WESTERLO EM, SMETSERS TF, WILLEMSE M, VAN MUIJEN GN, MERRY CL, GALLAGHER JT, KIM YS and VAN KUPPEVELT TH, 2004. The Journal of biological chemistry. 279(37), 38346-52
• BLACKHALL FH, MERRY CL, LYON M, JAYSON GC, FOLKMAN J, JAVAHERIAN K and GALLAGHER JT, 2003. The Biochemical journal. 375(Pt 1), 131-9
• MERRY CL and GALLAGHER JT, 2003. New insights into heparan sulphate biosynthesis from the study of mutant mice. Biochemical Society symposium. 47-57
• WILSON VA, GALLAGHER JT and MERRY CL, 2003. Glycoconjugate journal. 19(4-5), 347-54
• MERRY CL and WILSON VA, 2002. Role of heparan sulfate-2-O-sulfotransferase in the mouse. Biochimica et biophysica acta. 1573(3), 319-27
• MERRY CL, BULLOCK SL, SWAN DC, BACKEN AC, LYON M, BEDDINGTON RS, WILSON VA and GALLAGHER JT, 2001. The Journal of biological chemistry. 276(38), 35429-34
• BLACKHALL FH, MERRY CL, DAVIES EJ and JAYSON GC, 2001. British journal of cancer. 85(8), 1094-8
• MERRY CL, LYON M, DEAKIN JA, HOPWOOD JJ and GALLAGHER JT, 1999. The Journal of biological chemistry. 274(26), 18455-62